Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Robustness of convolutional neural networks in recognition of pigmented skin lesions
58
Zitationen
22
Autoren
2021
Jahr
Abstract
BACKGROUND: A basic requirement for artificial intelligence (AI)-based image analysis systems, which are to be integrated into clinical practice, is a high robustness. Minor changes in how those images are acquired, for example, during routine skin cancer screening, should not change the diagnosis of such assistance systems. OBJECTIVE: To quantify to what extent minor image perturbations affect the convolutional neural network (CNN)-mediated skin lesion classification and to evaluate three possible solutions for this problem (additional data augmentation, test-time augmentation, anti-aliasing). METHODS: We trained three commonly used CNN architectures to differentiate between dermoscopic melanoma and nevus images. Subsequently, their performance and susceptibility to minor changes ('brittleness') was tested on two distinct test sets with multiple images per lesion. For the first set, image changes, such as rotations or zooms, were generated artificially. The second set contained natural changes that stemmed from multiple photographs taken of the same lesions. RESULTS: All architectures exhibited brittleness on the artificial and natural test set. The three reviewed methods were able to decrease brittleness to varying degrees while still maintaining performance. The observed improvement was greater for the artificial than for the natural test set, where enhancements were minor. CONCLUSIONS: Minor image changes, relatively inconspicuous for humans, can have an effect on the robustness of CNNs differentiating skin lesions. By the methods tested here, this effect can be reduced, but not fully eliminated. Thus, further research to sustain the performance of AI classifiers is needed to facilitate the translation of such systems into the clinic.
Ähnliche Arbeiten
Dermatologist-level classification of skin cancer with deep neural networks
2017 · 13.437 Zit.
Tumor Angiogenesis: Therapeutic Implications
1971 · 10.108 Zit.
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
2011 · 7.668 Zit.
Pembrolizumab versus Ipilimumab in Advanced Melanoma
2015 · 5.803 Zit.
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
2017 · 5.354 Zit.
Autoren
- Roman C. Maron
- Sarah Haggenmüller
- Christof von Kalle
- Jochen Utikal
- Friedegund Meier
- Frank Friedrich Gellrich
- Axel Hauschild
- Lars E. French
- Max Schlaak
- Kamran Ghoreschi
- Heinz Kutzner
- Markus V. Heppt
- Sebastian Haferkamp
- Wiebke Sondermann
- Dirk Schadendorf
- Bastian Schilling
- Achim Hekler
- Eva Krieghoff‐Henning
- Jakob Nikolas Kather
- Stefan Fröhling
- Daniel B. Lipka
- Titus J. Brinker
Institutionen
- German Cancer Research Center(DE)
- Heidelberg University(DE)
- National Center for Tumor Diseases(DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin(DE)
- University Hospital Carl Gustav Carus(DE)
- Technische Universität Dresden(DE)
- University Hospital Schleswig-Holstein(DE)
- University of Lübeck(DE)
- University of Miami(US)
- LMU Klinikum(DE)
- Ludwig-Maximilians-Universität München(DE)
- Charité - Universitätsmedizin Berlin(DE)
- Dermatopathologie Friedrichshafen(DE)
- Universitätsklinikum Erlangen(DE)
- University Hospital Regensburg(DE)
- Essen University Hospital(DE)
- Universitätsklinikum Würzburg(DE)